Get started
LEGAL & GENERAL UCITS ETF PLC - L&G PHARMA BREAKTHROUGH UCITS ETFLEGAL & GENERAL UCITS ETF PLC - L&G PHARMA BREAKTHROUGH UCITS ETFLEGAL & GENERAL UCITS ETF PLC - L&G PHARMA BREAKTHROUGH UCITS ETF

LEGAL & GENERAL UCITS ETF PLC - L&G PHARMA BREAKTHROUGH UCITS ETF

No trades
See on Supercharts
Overview
Analysis Discussions Seasonals

ETLI chart


Full chart

Key stats


Assets under management (AUM)
‪15.90 M‬ EUR
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
—

About LEGAL & GENERAL UCITS ETF PLC - L&G PHARMA BREAKTHROUGH UCITS ETF


Issuer
Legal & General Group Plc
Brand
L&G
Expense ratio
0.49%
Home page
fundcentres.lgim.com
Inception date
Jan 23, 2018
Index tracked
Solactive Pharma Breakthrough Value Index
Management style
Passive
ISIN
IE00BF0H7608
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Multi-factor
Weighting scheme
Equal
Selection criteria
Multi-factor

ETLI analysis


What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
2%63%13%20%

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.